All Stories

  1. Revisiting the immunopathology of congenital disorders of glycosylation: an updated review
  2. Cardiolipin Membranes Promote Cytochrome c Transformation of Polycyclic Aromatic Hydrocarbons and Their In Vivo Metabolites
  3. Advancing cancer immunotherapy: from innovative preclinical models to clinical insights
  4. Altered expression of Sialyl Lewis X in experimental models of Parkinson’s disease
  5. Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
  6. Congenital disorders of glycosylation (CDG): state of the art in 2022
  7. Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors
  8. Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer
  9. A Community-Based Participatory Framework to Co-Develop Patient Education Materials (PEMs) for Rare Diseases: A Model Transferable across Diseases
  10. Patient reported outcomes for phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG): listening to what matters for the patients and health professionals
  11. A Participatory Framework for Plain Language Clinical Management Guideline Development
  12. Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)
  13. Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective
  14. Concerted Regulation of Glycosylation Factors Sustains Tissue Identity and Function
  15. Oxidative Stress and Inflammatory Response of Skin Fibroblasts Exposed to Chlorpyrifos
  16. Editorial: Biomarkers in Genitourinary Cancers, Volume I
  17. Targeting Immune-Mediated Responses to Tackle GNE Myopathy
  18. Registered human trials addressing environmental and occupational toxicant exposures: Scoping review of immunological markers and protective strategies
  19. Use of Lipid Vesicles for Revealing the Potential Contribution of Cytochrome C in the Metabolism of Environmental Toxicants
  20. A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation
  21. Comparison of Laccases and Hemeproteins Systems in Bioremediation of Organic Pollutants
  22. The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)
  23. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy
  24. Structural Insights in Mammalian Sialyltransferases and Fucosyltransferases: We Have Come a Long Way, but It Is Still a Long Way Down
  25. Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer
  26. Artificial Intelligence in Epigenetic Studies: Shedding Light on Rare Diseases
  27. Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis
  28. L1CAM as an E-selectin Ligand in Colon Cancer
  29. International consensus guidelines for phosphoglucomutase 1 deficiency ( PGM1‐CDG ): Diagnosis, follow‐up, and management
  30. New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach
  31. Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers
  32. Functional and Physiological Methods of Evaluating Median Nerve Regeneration in the Rat
  33. MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells
  34. Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?
  35. Carcinoembryonic antigen is a sialyl Lewis x/a carrier and an E‑selectin ligand in non‑small cell lung cancer
  36. CDG and immune response: From bedside to bench and back
  37. BD-2 and BD-3 increase skin flap survival in a model of ischemia and Pseudomonas aeruginosa infection
  38. Unconventional Perfusion Flaps in the Experimental Setting
  39. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up
  40. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications
  41. Application of Hyperthermia for Cancer Treatment: Synthesis and Characterization of Magnetic Nanoparticles and their internalization on Tumor Cell Lines
  42. International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up
  43. Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review
  44. Tools for the Screening of Sarcopenia: A Head-to-Head Comparison by the NOVA SarcoAging Group
  45. A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer
  46. Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
  47. Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
  48. Ligation of the CD44 Glycoform HCELL on Culture-Expanded Human Monocyte-Derived Dendritic Cells Programs Transendothelial Migration
  49. Halilectin-3, a Lectin from the Marine Sponge Haliclona caerulea, Induces Apoptosis and Autophagy in Human Breast Cancer MCF7 Cells Through Caspase-9 Pathway and LC3-II Protein Expression
  50. Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
  51. Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue
  52. CDG Therapies: From Bench to Bedside
  53. Reconstruction of a 10-mm-long median nerve gap in an ischemic environment using autologous conduits with different patterns of blood supply: A comparative study in the rat
  54. Antibacterial activity of a new lectin isolated from the marine sponge Chondrilla caribensis
  55. Dithiothreitol-based protein equalization technology to unravel biomarkers for bladder cancer
  56. Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1
  57. Correction: Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases
  58. Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods
  59. Structural characterization of two isolectins from the marine red alga Solieria filiformis (Kützing) P.W. Gabrielson and their anticancer effect on MCF-7 breast cancer cells
  60. E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy
  61. Green synthesis and structural characterization of completely decomposed granite (CDG) based geopolymer
  62. An Electronic Questionnaire for Liver Assessment in Congenital Disorders of Glycosylation (LeQCDG): A Patient-Centered Study
  63. Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation and ERK1/2 and p38 MAPK activation
  64. Reconstruction of a long defect of the ulnar artery and nerve with an arterialized neurovenous free flap in a teenager: A case report and literature review
  65. Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation
  66. Blood Supply to the Integument of the Abdomen of the Rat: A Surgical Perspective
  67. Optimization of an Arterialized Venous Fasciocutaneous Flap in the Abdomen of the Rat
  68. Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases
  69. Cell-Specific Variation in E-Selectin Ligand Expression among Human Peripheral Blood Mononuclear Cells: Implications for Immunosurveillance and Pathobiology
  70. Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage
  71. Liver involvement in congenital disorders of glycosylation (CDG). A systematic review of the literature
  72. A Model of Free Tissue Transfer: The Rat Epigastric Free Flap
  73. Glycosyltransferase inhibitors: a promising strategy to pave a path from laboratory to therapy
  74. Bioactivity gradients of cytoprotective and anticancer catechins in skin: Simulation studies for the design of controlled release systems
  75. Using dendritic cells to evaluate how Burkholderia cenocepacia clonal isolates from a chronically infected cystic fibrosis patient subvert immune functions
  76. Vaccine and Antibody Therapy Against Thomsen- Friedenreich Tumor-Associated Carbohydrate Antigens
  77. Systematic Review and Meta-Analysis of Unconventional Perfusion Flaps in Clinical Practice
  78. Immunological aspects of congenital disorders of glycosylation (CDG): a review
  79. Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses
  80. In vitro and in vivo biological characterization of the anti-proliferative potential of a cyclic trinuclear organotin(iv) complex
  81. Immature myeloid cells and tolerogenic cytokine profile in lung adenocarcinoma metastatic lymph nodes assessed by endobronchial ultrasound
  82. Challenges in Antibody Development against Tn and Sialyl-Tn Antigens
  83. Protein disulfide isomerases: Impact of thapsigargin treatment on their expression in melanoma cell lines
  84. Characterization of antiproliferative potential and biological targets of a copper compound containing 4′-phenyl terpyridine
  85. Sweet side of bladder cancer
  86. Characterization of the antiproliferative potential and biological targets of a trans ketoimine platinum complex
  87. Abstract 3163: Transendothelial migration of uveal melanoma cells
  88. Meeting report on EMBO Workshop: Glycobiology and glycochemistry, applications to human health and disease
  89. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells
  90. Intravital microscopy technique to study parasite dynamics in the labyrinth layer of the mouse placenta
  91. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer
  92. Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines
  93. Cytokeratin 19, Carcinoembryonic Antigen, and Epithelial Cell Adhesion Molecule Detect Lung Cancer Lymph Node Metastasis in Endobronchial Ultrasound-Guided Transbronchial Aspiration Samples
  94. Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy
  95. Overexpression of tumour-ssociated carbohydrate antigen sialyl-Tn in advanced bladder tumours
  96. Diagnostic value of endobronchial and endoscopic ultrasound-guided fine needle aspiration for accessible lung cancer lesions after non-diagnostic conventional techniques: a prospective study
  97. The phagocytic capacity and immunological potency of human dendritic cells is improved by α2,6‐sialic acid deficiency
  98. Biological targets of new metal compounds
  99. Dendritic Cells: A Spot on Sialic Acid
  100. Sialyl-Tn in Cancer: (How) Did We Miss the Target?
  101. Postprandial Insulin Resistance in Zucker Diabetic Fatty Rats is Associated with Parasympathetic‐Nitric Oxide Axis Deficiencies
  102. Bladder cancer–glycosylation insights
  103. Sialylation and dendritic cells: bridging innate and adaptive immune responses
  104. Understanding Postprandial Glucose Clearance by Peripheral Organs: The Role of the Hepatic Parasympathetic System
  105. The Role of Sugars in Dendritic Cell Trafficking
  106. Sialyl Lewisx-dependent binding of human monocyte-derived dendritic cells to selectins
  107. Screening of congenital cytomegalovirus infection by real-time PCR in urine pools
  108. Abstract 377: Multifunctional magnetic nanoparticles for theranostic applications
  109. IL-4 and TNF-α Polymorphisms Are Associated with Risk of Multiple Superficial Tumors or Carcinoma in situ Development
  110. Effects of Bevacizumab on Autocrine VEGF Stimulation in Bladder Cancer Cell Lines
  111. Human dendritic cells contain cell surface sialyltransferase activity
  112. ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines
  113. Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines
  114. Effect of sialic acid loss on dendritic cell maturation
  115. Regulatory cells, cytokine pattern and clinical risk factors for asthma in infants and young children with recurrent wheeze
  116. Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis
  117. Os factores genéticos da asma
  118. Sa.123. Sialylation on Human Monocyte-Derived Dendritic Cells
  119. Functional and Topological Analysis of the Burkholderia cenocepacia Priming Glucosyltransferase BceB, Involved in the Biosynthesis of the Cepacian Exopolysaccharide
  120. Studies on the Involvement of the Exopolysaccharide Produced by Cystic Fibrosis-Associated Isolates of the Burkholderia cepacia Complex in Biofilm Formation and in Persistence of Respiratory Infections
  121. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide
  122. Sphingomonas paucimobilis beta-glucosidase Bgl1: a member of a new bacterial subfamily in glycoside hydrolase family 1
  123. Cloning and sequence analysis of the ces10 gene encoding a Sphingomonas paucimobilis esterase
  124. Gellan gum biosynthesis in Sphingomonas paucimobilis ATCC 31461: Genes, enzymes and exopolysaccharide production engineering
  125. Biochemical characterization of the β-1,4-glucuronosyltransferase GelK in the gellan gum-producing strain Sphingomonas paucimobilis A.T.C.C. 31461
  126. Identification of the pgmG Gene, Encoding a Bifunctional Protein with Phosphoglucomutase and Phosphomannomutase Activities, in the Gellan Gum-Producing Strain Sphingomonas paucimobilis ATCC 31461